Abstract
Accelerated immune cell aging is well-recognized feature of Down Syndrome (DS), a condition caused by trisomy of human chromosome 21 (Hsa21). DS predisposes individuals to recurrent infections, autoimmunity, low bone mass and leukemia. To investigate potential connections between immune cell dysfunction or disruption in DS, serum transcriptomic and proteomic datasets from DS and euploid individuals were examined. High DS superoxide dismutase 1 (SOD1) mRNA expression was consistently found and was strongly associated with an increased odds of inflammatory co-occurring conditions such as pharyngitis. SOD1 mRNA overexpression was also associated with decreased M2-polarized macrophages, increased resting-memory CD4+ T cells, elevated serum interleukin-16 levels and interferon-γ protein levels, indicative of pathological pro-inflammatory immune dysregulation. SOD1 mRNA was co-overexpressed with glutathione and thioredoxin-dependent pathways, both are integral to the antioxidative responses and the generation of hydrogen sulfide (H2S). Although H2S overproduction in DS has been attributed to the overexpression of cystathionine-β-synthase (CBS), no consistent CBS mRNA elevation was observed in this study. Conversely, the increased expression of a thioredoxin-dependent cysteine catabolism pathway suggests noncanonical H2S overproduction in DS distinct from CBS. Our findings highlight the unexpected relationship between oxidative stress homeostasis and H2S overproduction in DS, extending beyond Hsa21 trisomy.
Introduction:
Down Syndrome (DS), the result of trisomy of human chromosome 21 (Hsa21) trisomy is the most common chromosomal abnormality in humans1. While key characteristics of DS include musculoskeletal anomalies, neurocognitive impairment and congenital heart defects, individuals with DS are also at a higher risk of chronic co-occurring conditions including recurrent respiratory infections, autoimmune diseases, hypothyroidism and transient myeloproliferative disorder1-7. Increased lifetime risks of immunological and hematological complications in DS have been associated with the pathological accumulation of intracellular oxidative and metabolic stress 6-8.
Oxidative and metabolic stress are well characterized features of DS molecular pathophysiology9. The overexpression of several Hsa21 genes have been linked to impaired mitochondrial function and electron leakage from the mitochondrial inner membrane electron transport chain, resulting in the generation of toxic reactive oxygen species (ROS)10. Notably among Hsa21 resident genes, superoxide dismutase 1 (SOD1) - a key component of the cellular response to ROS - is overexpressed in DS and potentially drives ROS generation. SOD1 catalyzes the dismutation of superoxide radical to hydrogen peroxide (H2O2)11, which is normally decomposed to water and diatomic oxygen by catalase and peroxiredoxins. A SOD1 excess relative to catalase has been observed in DS erythrocytes and was suggested to increase the intracellular accumulation of H2O2, the precursor to more damaging hydroxyl radicals through reactions with divalent metal ions such as Fe2+ 6,12-15. However, the distinct subcellular localizations of SOD1 and catalase – cytoplasmic and peroxisomal, respectively – suggest the SOD1/catalase ratio is insufficient to explain elevated H2O2 in non-erythrocyte cell types 16,17. Moreover, the relationship between the expression of SOD1 and catalysts of cytosolic H2O2 decomposition remains to be characterized.
In addition to oxidative stress, DS is also characterized by the increased generation of intracellular hydrogen sulfide (H2S), a well-documented and potent inhibitor of mitochondrial respiration 18-20. Several studies have linked excess H2S generation in DS to to the increased expression of another Hsa21 resident gene cystathionine-β-synthase (CBS)21-23. CBS catalyzes the conversion of homocysteine to cystathionine as part of the reverse transsulfuration pathway21-23. However, we have previously shown an absence of consistently elevated CBS protein in B lymphocytes from DS individuals18.Therefore, it seems likely that other metabolic processes catalyzed by non-Hsa21 enzymes contribute to the excess intracellular H2S in DS cells.
The increased activity of the enzyme 3-mercaptopyruvate sulfurtransferase (MPST) in DS fibroblasts is one such possibility that has been linked to H2S overproduction20,24. In addition, H2S generation though MPST-mediated cysteine catabolism is dependent on the presence of low molecular thiol peptides such as thioredoxins and glutathione, which are integral components of the cellular thiol antioxidant protein axis and whose activity is upregulated in response to oxidative stress25,26.
The potential links between ROS and H2S metabolism in DS are strengthened by data demonstrating that in addition to an antioxidant role, SOD1 is also an essential oxidizer of H2S 18,27. Furthermore, we have shown that the inhibition of SOD1 activity significantly increased H2S levels in DS B lymphocytes 18. In the current study, the relationship between drivers of increased oxidative stress including SOD1 and the transcription of response effectors was investigated to uncover links between ROS and H2S metabolism in DS.
Methods:
Data access:
Patient white blood cell (WBC) bulk messenger RNA (mRNA) sequencing (RNA-seq) and serum proteomics data were collected by the University of Colorado Linda Crnic Institute’s Human Trisome Project, aligned to the human reference genome using RSEM28 and made publicly available by the National Institutes of Health Investigation of Co-occurring conditions across the Lifespan to Understand Down syndromE (INCLUDE) data sharing program (https://portal.includedcc.org)2,3,29, supported by National Heart, Lung and Blood Institute grant U2CHL156291. All data analyzed in this report were collected under a protocol approved by the Colorado Multiple Institutional Review Board2 and de-identified prior to dissemination. Informed consent was obtained from all subjects and/or their legal guardian(s) prior to sample collection. All methods in this study were performed in accordance with the relevant guidelines and institutional regulations.
Analysis of bulk RNA-seq data:
Gene mRNA count data from 270 individuals with Down syndrome (DS) and 146 euploid individuals were aggregated in R 4.4.1 using the dplyr library30 (version 1.1.4; https://github.com/tidyverse/dplyr). The age range of participants was between 0.5 and 69.1 years, with 210 female and 206 male individuals. Gene counts were TMM-normalized to counts-per-million (CPM), low-expressed genes (CPM < 1.0) excluded from downstream analyses and differential gene expression in DS versus euploid assessed using edgeR (version 4.0) 31. P-values were calculated using the edgeR pipeline’s negative binomial model and likelihood ratio test for DS versus euploid mRNA expression and adjusted for multiple comparisons using the Benjamini-Hochberg procedure 32.
Analysis of serum proteomics data:
For individuals with mRNA expression data, serum proteomics data was also available for 260 euploid and 113 DS individuals. Serum proteomics profiles were aggregated, log2-normalized and tested for statistical significance between cohorts in R 4.4.1 using the dplyr and stats libraries 30.
Gene set enrichment analysis (GSEA) via active protein interaction subnetworks:
GSEA incorporating protein-protein interaction information was performed on log2-transformed mRNA expression fold changes obtained from the edgeR pipeline using the pathfindR library (version 2.4.1)33. In brief, protein-protein interaction information was obtained from the Search Tool for the Retrieval of Interacting Genes/Proteins (STRING) database and used to generate subnetworks of biologically related and differentially expressed genes. Subsequently, GSEA was performed on gene subnetworks and results mapped onto Reactome biological pathway gene sets34.
Analysis of clinical conditions:
Clinical diagnosis data from each of the 146 euploid and 270 DS individuals was obtained from the INCLUDE data sharing program and aggregated in R30. Cohorts of high and low SOD1-expressing DS individuals were defined as the 1st and 4th quartiles of DS SOD1 expression (n = 68 DS individuals, each), respectively. The prevalence of co-occurring conditions was calculated as the number of incidences of a condition divided by the total number of individuals in each cohort. Odds ratios for each condition in SOD1-high versus SOD1-low DS individuals were calculated as (incidences of condition, SOD1-high / incidences of condition, SOD1-low) / (individuals without condition, SOD1-high / individuals without condition, SOD1-low). The calculated odds ratios were tested for statistical significance in R against a null hypothesis of an odds ratio of 1 using Fisher’s exact tests and resulting P-values were adjusted for multiple comparisons using the Benjamini-Hochberg procedure32.
Immune Cell Subpopulation Inference:
Cohorts of high and low SQOR- and SOD1-expressing euploid and DS individuals were defined as the 1st (high) and 4th (low) quartiles of SQOR and SOD1 gene expression within each group separately. Bulk mRNA transcriptomics data for individuals in each of the 4 cohorts were deconvoluted using CIBERSORTx (http://cibersortx.stanford.edu) against the default peripheral blood cell signature matrix to obtain inferred immune cell frequencies 35.
Visualization:
All heatmaps were generated and hierarchically clustered using R 4.4.1 and the ComplexHeatmap36 library. Visualization of individual gene expression patterns across individuals was achieved using the ggforce library37. Linear regression analyses and visualization of gene expression P-values against log2-transformed fold changes were generated using the ggplot2 library.
Results:
The mRNA expression of most Hsa21 genes were identified as overexpressed (log2(Fold Change, DS vs. euploid) > 0) in DS WBCs relative to euploid, as demonstrated by others 2,3 (Figure 1). The mean mRNA log2(Fold Change) of significantly overexpressed Hsa21 genes was 0.626, corresponding to a fold change of 1.54 consistent with triplication of a constitutively expressed locus in Hsa21 trisomy. SOD1 was among a cluster of Hsa21 genes consistently overexpressed in DS individuals versus euploid. Similarly, mRNA overexpression of Hsa21 genes – NRIP1, SUMO3, DYRK1A, RCAN1, ETS2, PKNOX1/PREP1 - previously linked to decreased mitochondrial respiration efficiency and increased ROS generation – was also identified 38,39 (Supplementary Figure 1). In contrast, CBS mRNA was not significantly overexpressed in DS WBCs (Figure 1), implicating SOD1 and not CBS mRNA overexpression as a salient feature of the DS WBC transcriptome.
Figure 1: Variability in expression of Hsa21 genes in DS white blood cells relative to euploid, with more consistent superoxide dismutase 1 (SOD1) overexpression than cystathionine beta synthase (CBS) in DS.
Dots represent individual genes, with Hsa21 genes colored in blue. Significant overexpression of SOD1, but not CBS in Down Syndrome (DS) WBCs relative to euploid individuals. SOD1 among the most consistently overexpressed genes in DS WBCs (lower q-value). Gene expression fold changes calculated from comparisons between DS and euploid individuals using edgeR. Q-values were calculated from p-values following correction for multiple comparisons using the Benjamini-Hochberg method.
To profile the heterogeneity of DS and euploid WBC transcriptomes, topological data analysis was performed to group individuals based on similarities in mRNA expression40,41. As a metric of biological dissimilarity due to trisomy, an anomaly score was calculated using the Isolation Forest algorithm42 on normalized Hsa21 mRNA expression values from DS and euploid patient transcriptomics data. Hsa21 anomaly scores and the first component from Principal Component Analysis (PCA) were used as filter functions for the Mapper algorithm, which was then used to generate graphical representations that grouped individuals with similar transcriptional profiles into nodes40,43. Topological data analysis revealed a distinct separation between nodes predominated by DS and euploid individuals, with observed outward flaring of certain DS-dominant nodes suggesting transcriptional heterogeneity within the DS cohort (Figure 2A). While euploid-dominant nodes exhibited consistently lower mean nodal SOD1 expression, we noted considerable variation in SOD1 expression across DS dominant nodes, suggesting that a potential role for variability in SOD1 expression across DS individuals contributes to phenotypic variation in symptom severity.
Figure 2: Topological representation of RNA-seq data distinguishes euploid from DS individuals based on Hsa21 gene expression.
Graphs generated using an Isolation Forest anomaly score calculated from chromosome 21 gene expression values and Principal Component Analysis as filter functions for the Mapper algorithm. Nodes represent groups of individuals with similar mRNA expression profiles and edges represent similarities between nodes. A.) Coloring of nodes by fraction of DS individuals (“1” represents 100% of individuals in a node being from the DS cohort) revealed distinct separation of euploid-predominant nodes from DS based on chromosome 21 gene expression, with notable heterogeneity among DS-dominant nodes. B.) Coloring of nodes by mean SOD1 expression (greater values represent highest mRNA expression) indicated consistently lower SOD1 expression in euploid-dominant nodes albeit with considerable variation in mean nodal SOD1 expression across DS-dominant nodes, indicating that variability in SOD1 expression may contribute to phenotypic variation in DS severity.
Next, we determined whether SOD1 mRNA expression in DS individuals was associated with increased frequencies of co-occurring conditions. Cohorts of SOD1 high- and low-expressing DS individuals were defined as the 1st and 4th quartiles of DS SOD1 expression (Figure 3A). The ratios of prevalences of co-occurring conditions in both cohorts relative to all DS individuals in the dataset were calculated and visualized using hierarchical clustering44. A cluster of co-occurring conditions with increased prevalences in SOD1-high but decreased in SOD1-low DS individuals (Figure 3B) was observed, including several co-occurring conditions associated with overactive or dysregulated immune cell function. A significantly higher odds ratio for pharyngitis in SOD1-high DS individuals versus SOD1-low was observed. (Figure 3C). Recurrent respiratory infections (i.e. pharyngitis) and increased risk of autoimmunity (i.e. psoriasis and seborrheic dermatitis) have been previously associated with decreased B and T lymphocyte viability in DS4,7. Our results demonstrate that SOD1 overexpression may be associated with dysregulated immune cell function in DS, with adverse consequences to patient health.
Figure 3: Greater odds of immune dysfunction-associated conditions in DS individuals with higher SOD1 expression.
A). Strategy for the identification of highest and lowest SOD1 mRNA-expressing DS individuals. DS individuals expressing SOD1 mRNA at levels greater than the 75% percentile of all DS individuals in the dataset were designated as “SOD1-high” (n = 68 individuals), and those expressing SOD1 lower than the 25% percentile were designated as “SOD1-low” (n = 68 individuals). Y-axis indicates mRNA expression, measured as counts-per-million (cpm) following normalization by edgeR. Dots denote individuals. B). Heatmap of prevalences of co-occurring clinical conditions in DS individuals with highest (> 3rd quartile) and lowest (< 1st quartile) SOD1 mRNA expression, clustered hierarchically using Ward’s method. Color of each cell indicates ratio of prevalence of term in cohort relative to all DS individuals in data set (red: higher, blue: lower prevalence). A notable cluster of diseases were overrepresented in SOD1-high (left column) DS individuals (pharyngitis-autism spectrum disorder) and underrepresented in SOD1-low (right column) DS individuals. Bolded terms indicate diseases of dysregulated immune function within the first cluster, suggesting that increased SOD1 expression is associated with dysfunctional immune responses. C). Odds ratios of selected diseases in SOD1-high versus SOD1-low DS individuals. Significantly higher likelihood of pharyngitis in SOD1-high DS individuals versus SOD1-low (Fisher exact test p, adj. < 0.05). Trend toward higher odds ratio with psoriasis, hidradenitis suppurative and seborrheic dermatitis, all diseases of dysregulated immune activity. Dashed line represents odds ratio of 1. Error bars represent 95% confidence intervals of odds ratio. Log-scaled y-axis.
Another cluster of co-occurring conditions with increased prevalences in the SOD1-low DS cohort, included the prevalence of acute myeloid leukemia (Figure 3B). Both low and high SOD1 expression contribute to the elevated oxidative stress burden in DS. Low SOD1 expression may contribute via decreased dismutation of excess superoxide radicals, and high SOD1 expression via increased generation of hydrogen peroxide, a precursor to more damaging ROS such as the hydroxyl radical (HO*−)14. Our observations are entirely consistent with previous cellular studies linking elevated oxidative stress in DS to dysregulated hematopoiesis and an elevated risk for leukemia development5,8.
Since SOD1 also catalyzes the protective oxidation of H2S, we next compared the associations of high SOD1 expression with the canonical H2S-oxidizing enzyme sulfide:quinone oxidoreductase (SQOR) and immune cell frequencies in DS. As above, high and low SOD1 and SQOR expression were defined as the 1st and 4th quartiles respectively, in euploid and DS individuals. The bulk mRNA transcriptomic profile of individuals in each high- and low-expression cohort was deconvoluted using CIBERSORTx to infer immune cell subpopulation frequencies 35. In both euploid and DS, SQOR-high individuals had a significantly higher mean sample fraction of M2-polarized macrophages relative to respective SQOR-low (Figure 4A). Functionally different from pro-inflammatory M1 macrophages, M2-polarized macrophages are associated with wound healing and inflammation resolution 45. The greater M2-macrophage fraction in SQOR-high individuals is consistent with the idea that oxidized sulfur species increase M2 polarization, as shown previously by treatment with the long-acting H2S and polysulfide donor GYY4137. 46-48 49. It is possible that increased M2 polarization mitigates any pro-inflammatory macrophage activation in DS 3. As such, SQOR overexpression may be a potentially protective adaptation. In contrast, significantly lower M2 macrophage fraction in SOD1-high DS individuals was identified relative to SOD1-low DS (Figure 4B), suggesting a possible loss of resilience to a pro-inflammatory milieu with SOD1 overexpression.
Figure 4: Divergent trends in inferred M2 macrophage and resting memory CD4+ T cell populations in SQOR- and SOD1-overexpressing DS individuals.
Violin plots following deconvolution of bulk mRNA transcriptomic data from SQOR- and SOD1-high/low euploid and DS individuals revealed A.) increased M2 macrophage fractions in SQOR-high DS and euploid individuals relative to respective SQOR-low cohorts, yet B.) decreased M2 macrophage fractions in SOD1-high versus -low DS individuals but not in euploid, C.) decreased resting memory CD4+ T cell fractions in SQOR-high versus -low DS individuals but not in euploid, yet D.) increased resting memory CD4+ T cell fractions in SOD1-high versus -low individuals. These observations indicate that despite sharing a role as sulfide-oxidizing enzymes, SQOR overexpression is associated with resilience to inflammation while SOD1 overexpression is linked with a pro-inflammatory state in DS. High and low expression cohorts defined as the 1st and 4th quartiles of SQOR and SOD1 expression in euploid and DS separately. Dots indicate individuals. Kruskal-Wallis test, Dunn post-hoc. **:p < 1x10−2; ***:p < 1x10−3; ****:p < 1x10−4
Furthermore, significantly lower resting memory CD4+ T cells were also identified in SQOR-high versus SQOR-low DS (but not euploid) cohorts (Figure 4C). In addition, a significantly higher memory CD4+ T cells fraction was also observed in SOD1-high versus SOD1-low DS individuals (Figure 4D). Serum proteomic analysis revealed significantly higher levels of pro-inflammatory cytokines such as interleukin-16 (IL-16) and interferon gamma (IFN-γ) in SOD1-high versus SOD1-low DS (Figure 5A-B). While memory CD4+ T cells are essential for the coordination of innate and adaptive immune responses in healthy individuals 50, lower stimulus threshold for activation relative to non-memory cells has implicated them as drivers of autoimmunity 51. IL-16 is a crucial chemoattractant and activator of CD4+ T cells, which release IFN-γ to polarize macrophages into the M1 paradigm, thereby potentiating inflammation52,53. Indeed, an increased frequency of memory CD4+ T cells and elevated levels of IL-16 and IFN-γ are recognized as components of a hyperactive inflammatory state and correspondingly high risk of autoimmunity in DS 3,54. A greater fraction of memory CD4+ T cells is consistent with observations of higher inflammatory disease risk in SOD1-high DS individuals, and merits future investigation using single-cell transcriptomics and in vivo DS mouse models.
Figure 5: Elevated circulating levels of pro-inflammatory cytokines IL-16 and IFN-γ in SOD1-overexpressing DS individuals.
Violin plots of interleukin-16 (IL-16) and interferon-γ (IFN-γ) in SOD1-high/low euploid and DS individuals showed A.) higher serum IL-16 levels in SOD1-high DS individuals relative to all other cohorts and B.) higher serum IFN-γ levels, indicating a pro-inflammatory paradigm closely linked with hyperactive CD4+ T cell activity. Y-axes denote log-normalized mass spectrometric abundances. Dots represent individuals. Kruskal-Wallis test, Dunn post-hoc. *:p < 5x10−2; **:p < 1x10−2
Next, to understand whether SOD1 overexpression is associated with altered patterns of DS gene expression biological pathways co-overexpressed with SOD1 mRNA were examined using gene set enrichment analysis (GSEA). GSEA results were correlated with underlying biological mechanisms using active subnetworks of connections between biologically related genes. Individual genes that were significantly over- or under-expressed in DS were identified using the R pathfindR library, with protein-protein interaction information supplied from the Search Tool for the Retrieval of Interacting Genes/Proteins (STRING) database33,55. Subsequently, GSEA was performed on identified gene subnetworks and results mapped onto Reactome biological pathway gene sets56, identifying 484 significantly over- and underexpressed gene pathways in DS. Of the 484 pathway gene sets, only 1 pathway included SOD1 (“Cellular Response to Chemical Stress”, Reactome ID # R-HSA-9711123), which contains genes involved in the detoxification of reactive oxygen and nitrogen species (ROS and RNS, respectively). DS-overexpressed genes in this set included those involved in the synthesis (GCLC, GCLM) and regeneration (GSR) of reduced glutathione (GSH), an essential peptide co-reactant for ROS detoxification and the reversal of ROS-mediated injuries25 (Figure 6, 7A-C). The co-overexpression of SOD1 with genes involved in glutathione and thioredoxin/peroxiredoxin-mediated reversal of intracellular oxidative damage in DS suggests that oxidative consequences of SOD1 overexpression are linked with a reflexive cellular drive to mitigate ROS-mediated damage.
Figure 6: SOD1 co-overexpressed with oxidative stress response effectors.

Overexpressed genes (lower group) include those involved in the synthesis (GCLC, GCLM) and regeneration (GSR) of reduced glutathione, thioredoxins (TXN, TXN2) and superoxide dismutase 1 (SOD1). A group of under-expressed oxidative stress response effectors (upper) was also observed, including Nrf2 (NFE2L2), a small Maf co-activator of Nrf2 (MAFK) and a regulator of mitophagy (SQSTM1), potentially indicating decreased resilience to oxidative stress in DS. Rows represent genes, columns represent euploid (red header) or DS (aqua header) individuals, with cell color indicating the row-wise Z-score of normalized mRNA count-per-million values across all DS and euploid individuals combined (red: overexpression; blue: underexpression, relative to all individuals in dataset).
Figure 7: Overexpression of genes involved in glutathione metabolism in DS WBCs.

Violin plots highlight significantly higher expression of A.) glutathione synthase catalytic (GCLC) and B.) regulatory subunits (GCLM) as well as C.) glutathione reductase (GSR) in DS individuals relative to euploid, supporting increased thiol antioxidant demand in response to oxidative stress. Y-axis indicates mRNA expression, measured as counts-per-million (cpm) following normalization. Dots denote individuals. P-values calculated from comparisons between DS and euploid individuals through likelihood-ratio tests using edgeR and adjusted for multiple comparisons using the Benjamini-Hochberg correction to obtain q-values. ****: q < 1x10−8.
Also overexpressed in DS were thioredoxins (TXN, TXN2) and thioredoxin-dependent peroxiredoxins (PRDX1, PRDX2, PRDX3). Peroxiredoxins are essential, cysteine-containing enzymes that reduce H2O2 and organic (i.e. lipid, DNA) peroxides16, levels of which are pathologically elevated in cells from DS mouse15 and human models13,18,57. PRDX2 is the dominantly expressed cytosolic peroxiredoxin in WBCs and neurons 58 and was recently shown elevated in DS iPSC-derived neural progenitor cells 59. We report a significant positive correlation between SOD1 and PRDX2 mRNA expression in euploid and DS WBCs (Supplementary Figure 2). Also, SOD1/PRDX2 mRNA expression ratios were 23.5% higher in the DS cohort relative to euploid (Supplementary Figure 3). These findings suggest that DS WBCs exhibit excess SOD1-mediated H2O2 generation relative to cytosolic decomposition versus euploid cells, and that the overexpression of antioxidant effectors may not be sufficient to counteract ROS generation in DS.
Intriguingly, a subset of genes within the same “Cellular Response to Chemical Stress” gene set were significantly underexpressed in DS relative to euploid (NFE2L2, MAFK and SQSTM1) (Figure 6). NFE2L2 encodes the nuclear factor erythroid 2-related factor 2 (Nrf2) transcription factor which is co-activated by transcription factors of the small Maf family (i.e. MAFK) to stimulate the expression of antioxidative response genes60. Underexpression of NFE2L2 and MAFK mRNA in DS may therefore suggest an impaired capacity to activate Nrf2-regulated oxidative damage response effectors, potentially indicating decreased resilience to oxidative stress. Furthermore, the under expression of the mitophagy regulator sequestosome 1 (SQSTM1) has been linked to impaired mitophagy and accumulation of damaged mitochondria in DS cells, which exacerbates the oxidative stress burden via increased superoxide generation61. Our results are consistent with prior experimental data indicating decreased resilience to, and increased generation of ROS in DS cells 14,61 and support compensatory reliance on intracellular thiol antioxidant (glutathione and thioredoxin-mediated) systems.
The observation that SOD1 co-overexpression with thiol antioxidant system effectors has important implications for hydrogen sulfide (H2S) generation in DS cells. In addition to their essential role as co-reactants in cellular antioxidant pathways, glutathione and thioredoxin are important components of intracellular H2S detoxification and generation pathways respectively 26,49. H2S overproduction is a recognized feature of DS molecular pathophysiology 19,62 and is associated with decreased oxidative phosphorylation 18,19. Endogenous H2S generation can occur through cystathionine-β-synthase (CBS)- and cystathionine-γ-lyase (CTH)-dependent cysteine synthesis from homocysteine (reverse transsulfuration) and cysteine catabolism via 3-mercaptopyruvate sulfurtransferase (MPST)26. In the latter pathway, MPST reacts with the cysteine transamination catabolite 3-mercaptopyruvate, generating a persulfidated enzyme intermediate that can react with thioredoxins to liberate H2S26,63. Heatmap analysis of genes participating in sulfur amino acid metabolism (Reactome ID #R-HSA-1614635) indicated the overexpression of key genes related to thioredoxin/MPST-mediated H2S generation, including thioredoxin 2 (TXN2) and cytosolic (GOT1) as well as mitochondrial aspartate aminotransferase (GOT2), the latter 2 enzymes being the principal source of intracellular 3-mercaptopyruvate generation via cysteine transamination26,64 (Figure 8, 9A-B). In contrast, CTH mRNA was significantly under-expressed in DS individuals relative to euploid, and no significant difference in CBS expression was detected between DS and euploid. These results suggest that a cysteine transamination, MPST and thioredoxin-dependent axis drives the generation of excess H2S in DS WBCs.
Figure 8: Overexpression of genes participating in sulfur amino acid and hydrogen sulfide metabolism in DS WBCs.
mRNA expression analysis of genes involved in sulfur amino acid metabolism in euploid and DS WBCs reveals three groups: genes underexpressed (upper), overexpressed (lower) and similarly expressed (middle) in DS relative to euploid WBCs. Notably, components of the CBS and CTH-catalyzed reverse transsulfuration pathway were observed to be similarly or underexpressed respectively in DS, suggesting a lesser contributory role toward H2S generation. While MPST mRNA was also found to be similar across DS and euploid individuals, components of the cysteine catabolic pathway essential to MPST-catalyzed H2S generation – including cysteine aminotransferases (GOT1, GOT2) and thioredoxins (TXN2) – were overexpressed in DS. Furthermore, the expression of enzymes involved in H2S and polysulfide oxidation (SQOR, ETHE1) were also elevated across DS individuals relative to euploid. Together, these results support a stronger role of MPST in H2S overproduction and an increased drive toward H2S detoxification in DS WBCs. Rows represent genes, columns represent euploid (red header) or DS (aqua header) individuals, with cell color indicating the row-wise Z-score of normalized mRNA count-per-million values across all DS and euploid individuals combined (red: overexpression; blue: underexpression, relative to all individuals in dataset).
Figure 9: Overexpression of thioredoxins and key participants of hydrogen sulfide catabolism in DS.

Violin plots indicate significantly higher expression of A.) thioredoxin (TXN) and B.) thioredoxin 2 (TXN2) in DS - necessary reducing agents in MPST/thioredoxin-mediated H2S generation. Elevated expression of the sulfide catabolism enzymes C.) sulfide:quinone oxidoreductase (SQOR) and D.) persulfide dioxygenase (ETHE1) supports the existence of a cellular response to excess H2S in DS WBCs. Y-axis indicates mRNA expression, measured as counts-per-million (cpm) following normalization. Dots denote individuals. P-values calculated from comparisons between DS and euploid individuals through likelihood-ratio tests using edgeR and adjusted for multiple comparisons using the Benjamini-Hochberg correction to obtain q-values. ****: q < 1x10−8.
In addition to the CBS- and MPST-catalyzed routes, H2S can also be generated by cysteinyl-tRNA synthetases, which were not included in the Reactome list of genes participating in sulfur amino acid metabolism at the time of our analysis. While the expression of the cytosolic cysteinyl-tRNA synthetase 1 (CARS1) was not different between the two cohorts, the expression of the mitochondrial CARS2 was significantly lower in DS (Supplementary Figure 4). Together, these findings support a decreased role of CARS1/2-catalyzed generation toward H2S overproduction in DS WBCs.
Overexpression of sulfide:quinone oxidoreductase (SQOR) and persulfide dioxygenase (ETHE1) was also observed in DS versus euploid (Figure 8, 9C-D). SQOR and ETHE1 catalyze the canonical, glutathione-dependent detoxification of H2S to polysulfides and sulfite (SO32−) respectively, and their overexpression suggests a greater intracellular demand for H2S detoxification in DS49. To characterize the association, if any, between cysteine catabolism-linked H2S generation and H2S oxidation pathways in the context of DS, we used topological data analysis to visualize group dissimilarities in gene expression by calculating an anomaly score using the mRNA expression levels of MPST, SQOR, ETHE1, TXN2, TST, CTH, GOT1 and GOT2. We observed a notable separation between DS- and euploid-predominant nodes (Figure 10A), indicating that the expression of non-Hsa21 genes linked to sulfur metabolism can distinguish clusters of DS individuals from euploid independent of CBS expression. The concurrent overexpression of MPST (Figure 10B) and ETHE1 (Figure 10C) in DS-dominant nodes was also observed, suggesting elevated cysteine catabolism-linked H2S generation and sulfide oxidation. Additionally, significant positive correlations between MPST, TXN2 and ETHE1 mRNA – but not with CBS – in DS and euploid WBCs were observed, potentially indicating a stronger contributing role of an MPST-mediated H2S generation pathway to the sulfide burden in DS cells (Figure 11A-C).
Figure 10: Topological representation of mRNA profiles distinguishes euploid from DS individuals based on cysteine transamination and sulfur metabolic genes, excluding CBS.
Graphs generated using an Isolation Forest anomaly score calculated from the expression of non-chromosome 21 genes involved in cysteine catabolism-linked H2S generation – MPST, SQOR, ETHE1, TXN2, TST, CTH, GOT1, GOT2 - and Principal Component Analysis as filter functions for the Mapper algorithm. Nodes represent groups of individuals with similar mRNA expression profiles and edges represent similarities between nodes. A.) Coloring of nodes by fraction of DS individuals (“1” represents 100% of individuals in a node being from the DS cohort) reveals that expression of cysteine catabolism-associated genes separates DS-dominant nodes from euploid B.) Coloring of nodes by mean MPST expression (“1” represents highest mRNA expression) indicates higher MPST expression levels in DS-dominant nodes, concurrent with C) higher ETHE1 expression in DS-dominant nodes. Elevated MPST and ETHE1 suggest increased cysteine catabolism-linked H2S generation and oxidation respectively in DS cells.
Figure 11: Correlations of mRNA expression between H2S generation and oxidation pathways.
Significant positive correlations between A.) MPST (H2S generation) versus ETHE1 (H2S oxidation) and B.) TXN2 versus ETHE1 mRNA expression across euploid and DS WBCs, separately. C.) No significant correlation between CBS and ETHE1 observed, supporting a smaller role of CBS-mediated H2S production in WBCs. Gene expression values reported as normalized counts-per-million, with dots representing individuals (euploid n = 146; DS n = 270). Pearson’s r.
Discussion:
In this report, a novel transcriptomic and proteomic characterization uncovered an increased glutathione- and thioredoxin-dependent intracellular drive correlated with SOD1 overexpression and H2S overproduction in DS WBCs. An important limitation of transcriptomic investigations is that despite highlighting networks of gene regulation, mRNA levels do not imply protein levels inside cells. Similarly, serum proteomics does not convey information regarding the tissue-specific distribution and dynamics of inflammation in DS. Furthermore, our analyses of co-occurring clinical conditions are limited by variability in the presentation and reporting of clinical symptoms. Despite these limitations, however,our observations are consistent with a cellular response to reverse oxidative stress-mediated injuries, previously related empirically elevated ROS production and catabolismin multiple cell and animal models of DS6,8,12,14. Increased imputed fractions of pro-inflammatory CD4+ T cells and the inflammation-associated cytokines IL-16 and IFN-γ with SOD1 overexpression further implicate it as a contributor to immune dysregulation in DS3. Furthermore, the pro-inflammatory effects of SOD1 overexpression contrast with the anti-inflammatory M2 macrophage polarization with that of SQOR. Despite the protective H2S oxidizing function, excess SOD1 may negatively alter immune cell homeostasis in DS – a role that merits further investigation.
Others have identified mechanisms leading to the generation of excess oxidative stress in DS cells, such as SOD1 triplication12,65, altered proteostasis 66 and dysregulated clearance of damaged mitochondria61. However, the underlying mechanism(s) supporting resilience to oxidative damage in DS cells remain unclear. Prior clinical studies have shown increased activities of glutathione peroxidases in DS erythrocytes67,68 and protein levels of peroxiredoxins 1 and 2 in specific brain regions from DS patients 69.
Peroxiredoxins and glutathione peroxidases are enzyme families that reduce the inorganic (H2O2) and organic peroxides that arise due to ROS-mediated damage 16. Both classes depend on thiol-containing peptide co-reactants, thioredoxins and glutathione respectively, as essential reducing agents. Thioredoxins are a family of proteins (~12 kDa) that contain a conserved cysteine-glycine-proline-cysteine (CGPC) motif, allowing intramolecular disulfide bonds to form upon oxidation and constituting an integral aspect of their antioxidant function 70. Our findings of increased thioredoxin (TXN, TXN2) gene expression in DS WBCs suggest an increased intracellular demand for thiol antioxidant co-reactants to reverse oxidative damage. Increased transcription also suggests that normal NADPH-dependent regeneration of thioredoxins 70 is insufficient to meet heightened demand in DS cells. This idea is consistent with prior studies showing that DS neurons are more susceptible to cell death following inhibition of thioredoxin redox cycling with auranofin and indicate an increased sensitivity to thiol antioxidant depletion 71.
In addition to the overexpression of thioredoxins, our analyses uncover evidence for the increased regeneration and de novo synthesis of glutathione in DS. Glutathione is a tripeptide composed of glutamate, cysteine and glycine and is the most abundant endogenous antioxidant in humans72,73. As a co-reactant for antioxidant enzymes, reduced glutathione (GSH) donates electrons toward the reduction of organic peroxides, forming oxidized glutathione (GSSG). GSSG is a disulfide derived from two GSH molecules and can be reduced to regenerate GSH upon NADPH-dependent reduction in a reaction catalyzed by the enzyme glutathione reductase (GSR) 25. GSH can also be synthesized de novo, and the rate limiting step of GSH synthesis is the conjugation of cysteine to glutamate catalyzed by glutamate cysteine ligase (GCL), encoded by the GCLC and GCLM genes73.
The increased GSR gene expression reported here is a potential mechanism to explain reports of higher GSR activities in whole blood from DS individuals relative to euploid65, suggesting accelerated glutathione turnover due to increased oxidation. Garlet et al. 65 also reported that serum GSH levels were lower in DS individuals relative to euploid65. As such, a combination of decreased blood GSH together with elevated glutathione peroxidase activity may be indicative of an increased reliance on GSH-dependent antioxidant pathways leading to accelerated GSH depletion. Increased de novo synthesis of GSH - supported by GCLC and GCLM overexpression– provides a compensatory mechanism to replenish GSH stores within DS cells. Furthermore, GCLC and GCLM overexpression is concordant with increased serum cysteine levels in DS individuals relative to euploid controls 74, indicating increased cysteine import linked to de novo GSH synthesis. Our findings motivate further investigations into the post-transcriptional regulation of GCL activity and its contribution to inadequate matching of GSH supply and demand in DS cells.
In addition to its role as an essential antioxidant, GSH is also a co-reactant in mitochondrial sulfur oxidation pathways, an essential mechanism for intracellular H2S detoxification 26,49,75. In the presence of GSH, sulfide:quinone oxidoreductase (SQOR) acts in mitochondria to oxidize hydrogen sulfide 49 SQOR facilitates the transfer of sulfur atoms from H2S to form glutathione persulfides (GSSH), which are oxidized by ETHE1 (persulfide dioxygenase) and TST (thiosulfate sulfurtransferase) to yield sulfite and thiosulfate oxidation products respectively49. It is possible that H2S overproduction in DS contributes to increased GSH production as part of an increased need for H2S detoxification, an idea supported by the present findings of increased SQOR and ETHE1 gene expression in DS WBCs. An important caveat is that GSH and thioredoxin-dependent antioxidant effectors can also metabolize H2S and other reactive sulfur species (RSS) 76. The overlapping cellular responses to RSS and ROS make it difficult to distinguish the effects of one versus the other on the WBC transcriptome. Future experiments are therefore needed to determine the effects of glutathione and cysteine metabolism in DS on cellular responses to ROS and RSS.
Together with increased thiol antioxidant metabolism and regeneration, we report a correlation between increased cysteine catabolism and H2S generation in DS WBCs (Figure 12), but not with CBS. A lack of correlation between H2S overproduction and CBS levels is supported by our report of elevated H2S and polysulfide levels in DS B lymphocytes relative to euploid cells, despite no significant differences in CBS protein levels. 18. Differences in cell lineage may account for the notable variability in CBS overexpression across multiple systems in humans and animal models19 and thus, future experiments utilizing single-cell RNA sequencing to identify the effect of cell type on CBS expression will be useful. As mRNA expression and protein levels may not reflect protein activity, additional experiments are needed to evaluate post-translational and metabolic control of CBS activity in DS WBCs to better assess the contribution to H2S overproduction.
Figure 12: Pathways of cysteine catabolism, sulfide oxidation and the regeneration of the endogenous thiol antioxidants glutathione (GSH) and thioredoxins (TXN/2) are intimately linked and overexpressed in DS.
Green symbols represent genes transcriptionally overexpressed in DS WBCs. Reduced glutathione (GSH) is indicated in blue, and peroxidation (−OOH) is indicated in red. Cysteine is transaminated by aspartate aminotransferase (GOT1/2), generating 3-mercaptopyruvate (3-MP). The thiol group of 3-MP is transferred as a persulfide to 3-mercaptopyurvate sulfurtransferase (MPST), and released as H2S upon reaction with thioredoxins. mRNA overexpression of GOT1/2 and TXN/2 may thus drive H2S overproduction via accelerated cysteine catabolism in DS cells.
Removal of cytotoxic H2S from cells depends on GSH-mediated oxidation by sulfide:quinone oxidoreductase (SQOR), generating glutathione polysulfides (GSSH) which are converted to GSH by persulfide dioxygenase (ETHE1), generating sulfite (SO32−) and thiosulfate anions (S2O32−) after further reaction with thiosulfate sulfurtransferase (TST). H2S is also directly oxidized to polysulfides (HSn−) by SOD1, representing an alternative avenue of protective sulfide oxidation. Overexpression of SQOR, ETHE1 and SOD1 may indicate an increased drive toward sulfide oxidation due to a cytotoxic H2S excess in DS cells.
GSH synthesis and regeneration is also linked with cysteine metabolism through the de novo synthetic pathway catalyzed by glutamine-cysteine ligase (GCLC) and glutathione synthetase (GSS). GSH is an essential co-reactant for glutathione peroxidase-mediated reversal of lipid and protein peroxidation (R-OOH), a toxic consequence of reactive oxygen species (ROS). Overexpression of glutathione reductase (GSR) - an enzyme which regenerates GSH from oxidized (GSSG) glutathione – suggests a cellular response to increased ROS-mediated damage in DS cells, indicating concurrent oxidative and sulfide-mediated stress.
Other abbreviations:
α-KG: α-ketoglutarate; Glu: glutamine; Gly: glycine; CoQox, CoQred: oxidized and reduced coenzyme Q
In contrast, our findings of increased aminotransferase and thioredoxin expression implicate MPST as a potential driver of H2S overproduction in DS WBCs. MPST catalyzes the decomposition of 3-mercaptopyruvate to pyruvate and H2S in the presence of thiol-containing species such as lipoic acid, cysteine and thioredoxins26. 3-mercaptopyruvate, in turn, is generated from the transamination of cysteine by aspartate and glutamate aminotransferases (GOT1/2)75. GOT1/2 and TXN overexpression in DS. Therefore, these data suggest an enhanced capacity for MPST-mediated H2S generation through the excess generation and decomposition of 3-mercaptopyruvate, respectively. While a prior study by Panagaki et al. reported higher levels of MPST in DS dermal fibroblasts relative to euploid controls24, we did not observe significantly elevated MPST mRNA expression in DS WBCs26,75. It must be noted that MPST-mediated H2S generation is sensitive to the concentration of specific sulfide acceptors and increases together with thioredoxin concentrations at physiological levels 77. Increased thioredoxin expression in DS cells likely synergizes with MPST activity to drive H2S overproduction in the oxidatively stressed DS cell. 77
Our findings therefore suggest that H2S overproduction is a response to the oxidative consequences of Hsa21 trisomy. One such consequence is increased per-mitochondrion superoxide generation, previously attributed to dysregulated mitochondrial biogenesis and autophagy dynamics 14,61,78. As H2S directly reacts with superoxide 79, reflexive upregulation of H2S production may serve as a protective buffer against increased trisomy 21-related mitochondrial ROS generation. H2S also serves as the precursor for polysulfides, which readily react with superoxide 62,80 and modify cysteine residues by persulfidation. Cysteine persulfidation is protective modification which shields its side chain sulfur from irreversible ROS-mediated oxidation, thus preserving its essential catalytic function in various proteins 81. Particularly, the persulfidation of active site cysteines in PRDX2 protect it against H2O2-mediated overoxidation, which would otherwise lead to the formation of catalytically inactive aggregates 58,82. A larger “polysulfide pool” because of increased H2S generation may thus promote cellular resilience to ROS in DS, meriting further study. Despite its potential protective effects, it is still possible that H2S overproduction represents a “metabolic overcorrection” to increased ROS generation in DS, and future investigations are needed to determine the mechanisms that sustain overproduction in the absence of CBS overproduction.
In summary, we report a series of novel mechanisms underlying a thiol antioxidant axis-driven response to oxidative stress in DS WBCs that provides a possible explanation for H2S overproduction. Future studies targeting the crosstalk between ROS and H2S metabolism are warranted to improve WBC health and their effects on immune function in DS.
Supplementary Material
Acknowledgments:
Funding:
National Institutes of Health Grant R01NS094535 (TAK) Welch Foundation Grant BE-0048 (TAK)
National Institutes of Health Grant R01HD102909 (LJS)
National Science Foundation Grant IO2012106 (KRO)
Footnotes
Competing interests: The universities own intellectual property on H2S oxidation with application to DS-related accelerated aging, for which P.J.D. and T.A.K. are inventors. Conflicts of interest for P.J.D. and T.A.K. are mitigated through regular disclosure to and compliance with the Texas A&M Office of Sponsored Programs.
Data and materials availability: All data needed to evaluate the conclusions in this report may be accessed at https://portal.includedcc.org and are available upon request to the Human Trisome Project at dsresearch@cuanschutz.edu.
References:
- 1.Antonarakis S. E. et al. Down syndrome. Nat Rev Dis Primers 6, 9, doi: 10.1038/s41572-019-0143-7 (2020). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Donovan M. G. et al. Variegated overexpression of chromosome 21 genes reveals molecular and immune subtypes of Down syndrome. Nature Communications 15, 5473, doi: 10.1038/s41467-024-49781-1 (2024). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Galbraith M. D. et al. Multidimensional definition of the interferonopathy of Down syndrome and its response to JAK inhibition. Science Advances 9, eadg6218, doi: 10.1126/sciadv.adg6218. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Ghezzi M. et al. Recurrent Respiratory Infections in Children with Down Syndrome: A Review. Children (Basel) 11, doi: 10.3390/children11020246 (2024). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Hasaart K. A. L., Bertrums E. J. M., Manders F., Goemans B. F. & van Boxtel R. Increased risk of leukaemia in children with Down syndrome: a somatic evolutionary view. Expert Rev Mol Med 23, e5, doi: 10.1017/erm.2021.6 (2021). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Marcovecchio G. E. et al. Premature Senescence and Increased Oxidative Stress in the Thymus of Down Syndrome Patients. Front Immunol 12, 669893, doi: 10.3389/fimmu.2021.669893 (2021). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Ram G. & Chinen J. Infections and immunodeficiency in Down syndrome. Clin Exp Immunol 164, 9–16, doi: 10.1111/j.1365-2249.2011.04335.x (2011). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Marderstein A. R. et al. Single-cell multi-omics map of human fetal blood in Down syndrome. Nature 634, 104–112, doi: 10.1038/s41586-024-07946-4 (2024). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Dierssen M., Fructuoso M., Martínez de Lagrán M., Perluigi M. & Barone E. Down Syndrome Is a Metabolic Disease: Altered Insulin Signaling Mediates Peripheral and Brain Dysfunctions. Front Neurosci 14, 670, doi: 10.3389/fnins.2020.00670 (2020). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Roizen N. J. & Patterson D. Down's syndrome. Lancet 361, 1281–1289, doi: 10.1016/s0140-6736(03)12987-x (2003). [DOI] [PubMed] [Google Scholar]
- 11.Juarez J. C. et al. Superoxide dismutase 1 (SOD1) is essential for H2O2-mediated oxidation and inactivation of phosphatases in growth factor signaling. Proc Natl Acad Sci U S A 105, 7147–7152, doi: 10.1073/pnas.0709451105 (2008). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Gulesserian T., Seidl R., Hardmeier R., Cairns N. & Lubec G. Superoxide dismutase SOD1, encoded on chromosome 21, but not SOD2 is overexpressed in brains of patients with Down syndrome. J Investig Med 49, 41–46, doi: 10.2310/6650.2001.34089 (2001). [DOI] [PubMed] [Google Scholar]
- 13.Muchová J. et al. Influence of age on activities of antioxidant enzymes and lipid peroxidation products in erythrocytes and neutrophils of Down syndrome patients. Free Radic Biol Med 31, 499–508, doi: 10.1016/s0891-5849(01)00609-8 (2001). [DOI] [PubMed] [Google Scholar]
- 14.Perluigi M. & Butterfield D. A. Oxidative Stress and Down Syndrome: A Route toward Alzheimer-Like Dementia. Curr Gerontol Geriatr Res 2012, 724904, doi: 10.1155/2012/724904 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Ishihara K. et al. Increased lipid peroxidation in Down's syndrome mouse models. J Neurochem 110, 1965–1976, doi: 10.1111/j.1471-4159.2009.06294.x (2009). [DOI] [PubMed] [Google Scholar]
- 16.Perkins A., Nelson K. J., Parsonage D., Poole L. B. & Karplus P. A. Peroxiredoxins: guardians against oxidative stress and modulators of peroxide signaling. Trends Biochem Sci 40, 435–445, doi: 10.1016/j.tibs.2015.05.001 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Purdue P. E. & Lazarow P. B. Targeting of human catalase to peroxisomes is dependent upon a novel COOH-terminal peroxisomal targeting sequence. J Cell Biol 134, 849–862, doi: 10.1083/jcb.134.4.849 (1996). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Mouli K. et al. SOD1 Is an Integral Yet Insufficient Oxidizer of Hydrogen Sulfide in Trisomy 21 B Lymphocytes and Can Be Augmented by a Pleiotropic Carbon Nanozyme. Antioxidants 13, 1361 (2024). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Szabo C. The re-emerging pathophysiological role of the cystathionine-β-synthase - hydrogen sulfide system in Down syndrome. Febs j 287, 3150–3160, doi: 10.1111/febs.15214 (2020). [DOI] [PubMed] [Google Scholar]
- 20.Szabo C. Role of cystathionine-β-synthase and hydrogen sulfide in down syndrome. Neurotherapeutics, e00584, doi: 10.1016/j.neurot.2025.e00584 (2025). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Kamoun P., Belardinelli M. C., Chabli A., Lallouchi K. & Chadefaux-Vekemans B. Endogenous hydrogen sulfide overproduction in Down syndrome. Am J Med Genet A 116a, 310–311, doi: 10.1002/ajmg.a.10847 (2003). [DOI] [PubMed] [Google Scholar]
- 22.Panagaki T. et al. Neurobehavioral dysfunction in a mouse model of Down syndrome: upregulation of cystathionine β-synthase, H(2)S overproduction, altered protein persulfidation, synaptic dysfunction, endoplasmic reticulum stress, and autophagy. Geroscience 46, 4275–4314, doi: 10.1007/s11357-024-01146-8 (2024). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Panagaki T., Randi E. B., Augsburger F. & Szabo C. Overproduction of H2S, generated by CBS, inhibits mitochondrial Complex IV and suppresses oxidative phosphorylation in Down syndrome. Proceedings of the National Academy of Sciences 116, 18769–18771, doi:doi: 10.1073/pnas.1911895116 (2019). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Panagaki T., Randi E. B. & Szabo C. Role of 3-Mercaptopyruvate Sulfurtransferase in the Regulation of Proliferation and Cellular Bioenergetics in Human Down Syndrome Fibroblasts. Biomolecules 10, doi: 10.3390/biom10040653 (2020). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Couto N., Wood J. & Barber J. The role of glutathione reductase and related enzymes on cellular redox homoeostasis network. Free Radic Biol Med 95, 27–42, doi: 10.1016/j.freeradbiomed.2016.02.028 (2016). [DOI] [PubMed] [Google Scholar]
- 26.Pedre B. & Dick T. P. 3-Mercaptopyruvate sulfurtransferase: an enzyme at the crossroads of sulfane sulfur trafficking. 402, 223–237, doi:doi: 10.1515/hsz-2020-0249 (2021). [DOI] [PubMed] [Google Scholar]
- 27.Switzer C. H., Kasamatsu S., Ihara H. & Eaton P. SOD1 is an essential H(2)S detoxifying enzyme. Proc Natl Acad Sci U S A 120, e2205044120, doi: 10.1073/pnas.2205044120 (2023). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Li B. & Dewey C. N. RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinformatics 12, 323, doi: 10.1186/1471-2105-12-323 (2011). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Espinosa J. The Human Trisome Project. doi: 10.71738/P0A9-2V09 (2022). [DOI] [Google Scholar]
- 30.Wickham H. et al. Welcome to the Tidyverse. Journal of Open Source Software 4, 1686, doi: 10.21105/joss.01686 (2019). [DOI] [Google Scholar]
- 31.Robinson M. D., McCarthy D. J. & Smyth G. K. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26, 139–140, doi: 10.1093/bioinformatics/btp616 (2010). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Benjamini Y., Drai D., Elmer G., Kafkafi N. & Golani I. Controlling the false discovery rate in behavior genetics research. Behav Brain Res 125, 279–284, doi: 10.1016/s0166-4328(01)00297-2 (2001). [DOI] [PubMed] [Google Scholar]
- 33.Ulgen E., Ozisik O. & Sezerman O. U. pathfindR: An R Package for Comprehensive Identification of Enriched Pathways in Omics Data Through Active Subnetworks. Front Genet 10, 858, doi: 10.3389/fgene.2019.00858 (2019). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Fabregat A. et al. Reactome pathway analysis: a high-performance in-memory approach. BMC Bioinformatics 18, 142, doi: 10.1186/s12859-017-1559-2 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Newman A. M. et al. Determining cell type abundance and expression from bulk tissues with digital cytometry. Nature Biotechnology 37, 773–782, doi: 10.1038/s41587-019-0114-2 (2019). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Gu Z., Eils R. & Schlesner M. Complex heatmaps reveal patterns and correlations in multidimensional genomic data. Bioinformatics 32, 2847–2849, doi: 10.1093/bioinformatics/btw313 (2016). [DOI] [PubMed] [Google Scholar]
- 37.Pedersen T. L. ggforce: Accelerating 'ggplot2'. (2025). [Google Scholar]
- 38.Izzo A. et al. Mitochondrial dysfunction in down syndrome: molecular mechanisms and therapeutic targets. Molecular Medicine 24, 2, doi: 10.1186/s10020-018-0004-y (2018). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Vilardell M. et al. Meta-analysis of heterogeneous Down Syndrome data reveals consistent genome-wide dosage effects related to neurological processes. BMC Genomics 12, 229, doi: 10.1186/1471-2164-12-229 (2011). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Kepler Mapper: A flexible Python implementation of the Mapper algorithm v. v2.0.1 (Zenodo, 2021). [Google Scholar]
- 41.van Veen H. J., Saul N., Eargle D. & Mangham S. W. Kepler Mapper: A flexible Python implementation of the Mapper algorithm. Journal of Open Source Software 4, 1315, doi: 10.21105/joss.01315 (2019). [DOI] [Google Scholar]
- 42.Liu F. T., Ting K. M. & Zhou Z.-H. Isolation-Based Anomaly Detection. ACM Trans. Knowl. Discov. Data 6, Article 3, doi: 10.1145/2133360.2133363 (2012). [DOI] [Google Scholar]
- 43.Singh G., Memoli F. & Carlsson G. in Eurographics Symposium on Point-Based Graphics (eds Botsch M., Pajarola R., Chen B., & Zwicker M.) (The Eurographics Association, 2007). [Google Scholar]
- 44.Murtagh F. & Legendre P. Ward’s Hierarchical Agglomerative Clustering Method: Which Algorithms Implement Ward’s Criterion? Journal of Classification 31, 274–295, doi: 10.1007/s00357-014-9161-z (2014). [DOI] [Google Scholar]
- 45.Rőszer T. Understanding the Mysterious M2 Macrophage through Activation Markers and Effector Mechanisms. Mediators of Inflammation 2015, 816460, doi: 10.1155/2015/816460 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Sun F. et al. The role of hydrogen sulphide signalling in macrophage activation. Immunology 162, 3–10, doi: 10.1111/imm.13253 (2021). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Geng W. et al. Nitric Oxide Scavenging and Hydrogen Sulfide Production Synergistically Treat Rheumatoid Arthritis. Adv Healthc Mater 12, e2202380, doi: 10.1002/adhm.202202380 (2023). [DOI] [PubMed] [Google Scholar]
- 48.Greiner R. et al. Polysulfides link H2S to protein thiol oxidation. Antioxid Redox Signal 19, 1749–1765, doi: 10.1089/ars.2012.5041 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Landry A. P., Ballou D. P. & Banerjee R. Hydrogen Sulfide Oxidation by Sulfide Quinone Oxidoreductase. Chembiochem 22, 949–960, doi: 10.1002/cbic.202000661 (2021). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.MacLeod M. K., Clambey E. T., Kappler J. W. & Marrack P. CD4 memory T cells: what are they and what can they do? Semin Immunol 21, 53–61, doi: 10.1016/j.smim.2009.02.006 (2009). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Raphael I., Joern R. R. & Forsthuber T. G. Memory CD4(+) T Cells in Immunity and Autoimmune Diseases. Cells 9, doi: 10.3390/cells9030531 (2020). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Niewold T. B., Lehman J. S., Gunnarsson I., Meves A. & Oke V. Role of interleukin-16 in human diseases: a novel potential therapeutic target. Frontiers in Immunology Volume 16 - 2025, doi: 10.3389/fimmu.2025.1524026 (2025). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Ivashkiv L. B. IFNγ: signalling, epigenetics and roles in immunity, metabolism, disease and cancer immunotherapy. Nature Reviews Immunology 18, 545–558, doi: 10.1038/s41577-018-0029-z (2018). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Malle L. et al. Autoimmunity in Down's syndrome via cytokines, CD4 T cells and CD11c(+) B cells. Nature 615, 305–314, doi: 10.1038/s41586-023-05736-y (2023). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Szklarczyk D. et al. The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res 51, D638–d646, doi: 10.1093/nar/gkac1000 (2023). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Milacic M. et al. The Reactome Pathway Knowledgebase 2024. Nucleic Acids Res 52, D672–d678, doi: 10.1093/nar/gkad1025 (2024). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Seidl R. et al. Evidence against increased oxidative DNA-damage in Down syndrome. Neurosci Lett 235, 137–140, doi: 10.1016/s0304-3940(97)00748-9 (1997). [DOI] [PubMed] [Google Scholar]
- 58.Sadowska-Bartosz I. & Bartosz G. Peroxiredoxin 2: An Important Element of the Antioxidant Defense of the Erythrocyte. Antioxidants (Basel) 12, doi: 10.3390/antiox12051012 (2023). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Prutton K. M. et al. Oxidative stress as a candidate mechanism for accelerated neuroectodermal differentiation due to trisomy 21. Free Radical Biology and Medicine 186, 32–42, doi: 10.1016/j.freeradbiomed.2022.04.015 (2022). [DOI] [PubMed] [Google Scholar]
- 60.Hiebert P. The Nrf2 transcription factor: A multifaceted regulator of the extracellular matrix. Matrix Biology Plus 10, 100057, doi: 10.1016/j.mbplus.2021.100057 (2021). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Bordi M. et al. mTOR hyperactivation in Down Syndrome underlies deficits in autophagy induction, autophagosome formation, and mitophagy. Cell Death Dis 10, 563, doi: 10.1038/s41419-019-1752-5 (2019). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62.Derry P. J. et al. Oxidation of Hydrogen Sulfide to Polysulfide and Thiosulfate by a Carbon Nanozyme: Therapeutic Implications with an Emphasis on Down Syndrome. Advanced Materials 36, 2211241, doi: 10.1002/adma.202211241 (2024). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63.Hanaoka K. et al. Discovery and Mechanistic Characterization of Selective Inhibitors of H(2)S-producing Enzyme: 3-Mercaptopyruvate Sulfurtransferase (3MST) Targeting Active-site Cysteine Persulfide. Sci Rep 7, 40227, doi: 10.1038/srep40227 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64.Hipólito A., Nunes S. C., Vicente J. B. & Serpa J. Cysteine Aminotransferase (CAT): A Pivotal Sponsor in Metabolic Remodeling and an Ally of 3-Mercaptopyruvate Sulfurtransferase (MST) in Cancer. Molecules 25, doi: 10.3390/molecules25173984 (2020). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65.Garlet T. R. et al. Systemic oxidative stress in children and teenagers with Down syndrome. Life Sci 93, 558–563, doi: 10.1016/j.lfs.2013.08.017 (2013). [DOI] [PubMed] [Google Scholar]
- 66.Aivazidis S. et al. The burden of trisomy 21 disrupts the proteostasis network in Down syndrome. PLoS One 12, e0176307, doi: 10.1371/journal.pone.0176307 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 67.Gromadzińska J., Wasowicz W., Sktodowska M. & Stróżyński H. Glutathione Peroxidase Activity, Lipid Peroxides and Selenium Status in Blood in Patients with Down’s Syndrome. Clinical Chemistry and Laboratory Medicine (CCLM) 26, 255–258, doi:doi: 10.1515/cclm.1988.26.5.255 (1988). [DOI] [PubMed] [Google Scholar]
- 68.Francisco Javier O., Manuel R. & Manuel R. R. Regular physical activity increases glutathione peroxidase activity in adolescents with Down syndrome. Clin J Sport Med 16, 355–356, doi: 10.1097/00042752-200607000-00013 (2006). [DOI] [PubMed] [Google Scholar]
- 69.Sánchez-Font M. F. et al. Peroxiredoxin 2 (PRDX2), an antioxidant enzyme, is underexpressed in Down syndrome fetal brains. Cell Mol Life Sci 60, 1513–1523, doi: 10.1007/s00018-003-3048-1 (2003). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 70.Lu J. & Holmgren A. The thioredoxin antioxidant system. Free Radical Biology and Medicine 66, 75–87, doi: 10.1016/j.freeradbiomed.2013.07.036 (2014). [DOI] [PubMed] [Google Scholar]
- 71.Roede J. 324 - Investigation of cytoplasmic and mitochondrial redox status in Down syndrome: impact of the thioredoxin and glutathione systems. Free Radical Biology and Medicine 128, S134, doi: 10.1016/j.freeradbiomed.2018.10.354 (2018). [DOI] [Google Scholar]
- 72.Forman H. J., Zhang H. & Rinna A. Glutathione: overview of its protective roles, measurement, and biosynthesis. Mol Aspects Med 30, 1–12, doi: 10.1016/j.mam.2008.08.006 (2009). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 73.Franklin C. C. et al. Structure, function, and post-translational regulation of the catalytic and modifier subunits of glutamate cysteine ligase. Mol Aspects Med 30, 86–98, doi: 10.1016/j.mam.2008.08.009 (2009). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 74.Pogribna M. et al. Homocysteine metabolism in children with Down syndrome: in vitro modulation. Am J Hum Genet 69, 88–95, doi: 10.1086/321262 (2001). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 75.Nagahara N. & Sawada N. The mercaptopyruvate pathway in cysteine catabolism: a physiologic role and related disease of the multifunctional 3-mercaptopyruvate sulfurtransferase. Curr Med Chem 13, 1219–1230, doi: 10.2174/092986706776360914 (2006). [DOI] [PubMed] [Google Scholar]
- 76.Olson K. R. Are Reactive Sulfur Species the New Reactive Oxygen Species? Antioxidants & Redox Signaling 33, 1125–1142, doi: 10.1089/ars.2020.8132 (2020). [DOI] [PubMed] [Google Scholar]
- 77.Mikami Y. et al. Thioredoxin and dihydrolipoic acid are required for 3-mercaptopyruvate sulfurtransferase to produce hydrogen sulfide. Biochemical Journal 439, 479–485, doi: 10.1042/bj20110841 (2011). [DOI] [PubMed] [Google Scholar]
- 78.Helguera P. et al. Adaptive downregulation of mitochondrial function in down syndrome. Cell Metab 17, 132–140, doi: 10.1016/j.cmet.2012.12.005 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 79.Marini E. et al. Comparative Study of Different H2S Donors as Vasodilators and Attenuators of Superoxide-Induced Endothelial Damage. Antioxidants 12, 344 (2023). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 80.Olson K. R. H2S and polysulfide metabolism: Conventional and unconventional pathways. Biochemical Pharmacology 149, 77–90, doi: 10.1016/j.bcp.2017.12.010 (2018). [DOI] [PubMed] [Google Scholar]
- 81.Vignane T. & Filipovic M. R. Emerging Chemical Biology of Protein Persulfidation. Antioxid Redox Signal 39, 19–39, doi: 10.1089/ars.2023.0352 (2023). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 82.Dóka É. et al. Control of protein function through oxidation and reduction of persulfidated states. Science Advances 6, eaax8358, doi:doi: 10.1126/sciadv.aax8358 (2020). [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.









